PreciseInhale

– Knowledge gets Results –

Our dry powder aerosol R&D system, PreciseInhale, generates aerosols and data of a quality that until recently was unobtainable.

Uniquely, it shows how particles behave in all regions of the lung, early on. It helps eliminate poor Candidate Drugs before clincial trials. And it lets researchers set the exact dose of aerosol, and generate even, controllable dry powder aerosol from tiny amounts of even challenging test substances.

Our vision is for PreciseInhale to become the standard R&D tool for inhalation research worldwide. Our clients include the Dow Chemical Group, Kings College London and many more. We have the knowledge. We can deliver the results. Find out more today.

PreciseInhale

– Knowledge gets Results –

Our dry powder aerosol R&D system, PreciseInhale, generates aerosols and data of a quality that until recently was unobtainable.

Uniquely, it shows how particles behave in all regions of the lung, early on. It helps eliminate poor Candidate Drugs before clincial trials. And it lets researchers set the exact dose of aerosol, and generate even, controllable dry powder aerosol from tiny amounts of even challenging test substances.

Our vision is for PreciseInhale to become the standard R&D tool for inhalation research worldwide. Our clients include the Dow Chemical Group, Kings College London and many more. We have the knowledge. We can deliver the results. Find out more today.

News room

ISAB technology ubiquity at DDL27

  • 14 December, 2016

ISAB technology was profiled in two King’s College London posters and cited by a Pat Burnell New Innovation Award nominee at DDL27. “It reflects our…
Read more

ISAB talks bioaerosols in Tours

  • 14 September, 2016

Bioaerosols: What will be the biological effects? On September 4-9 ISAB took PreciseInhale to Tours in central France for the European Aerosol Assembly’s (EAA’s) 2016…
Read more